Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue

NCT00004107 is registered in ClinicalTrials.gov with Garden State Cancer Center at the Center for Molecular Medicine and Immunology as lead sponsor.

NCT NCT00004107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue
Lead sponsor
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 1998
Completion date
Not reported
Enrollment
18 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma